• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

皮肤临床I期恶性黑色素瘤生存和复发的预后因素比较

Comparison of prognostic factors for survival and recurrence in malignant melanoma of the skin, clinical Stage I.

作者信息

Johnson O K, Emrich L J, Karakousis C P, Rao U, Greco W R

出版信息

Cancer. 1985 Mar 1;55(5):1107-17. doi: 10.1002/1097-0142(19850301)55:5<1107::aid-cncr2820550528>3.0.co;2-c.

DOI:10.1002/1097-0142(19850301)55:5<1107::aid-cncr2820550528>3.0.co;2-c
PMID:3967194
Abstract

Potential prognostic factors for survival time, 5-year survival rate, recurrence-free time, and 5-year recurrence-free rate were explored for 262 patients with malignant melanoma of the skin, Stage I, using the long-rank test, proportional hazards (Cox) regression, and linear logistic regression. Breslow's thickness was the most important variable in each analysis. A thinner Breslow's thickness was associated with a better prognosis. After adjusting for Breslow's thickness, sex was the next most important variable in each analysis. Women had a better prognosis than men. After adjusting for Breslow's thickness and sex, there were no additional significant prognostic factors for survival time; Clark's level was significant for 5-year survival rate; the number of mitoses, evidence of regression, and presence of vascular invasion were significant for recurrence-free time; and the presence of vascular invasion and number of mitoses were significant for 5-year recurrence-free rate. It is recommended that in future prospective studies of adjuvant therapy of Stage I melanoma, patients be stratified into treatment groups on the basis of Breslow's thickness and sex.

摘要

采用对数秩检验、比例风险(Cox)回归和线性逻辑回归,对262例I期皮肤恶性黑色素瘤患者的生存时间、5年生存率、无复发生存时间和5年无复发率的潜在预后因素进行了探讨。在每项分析中,Breslow厚度都是最重要的变量。Breslow厚度越薄,预后越好。在调整Breslow厚度后,性别是每项分析中的第二重要变量。女性的预后比男性好。在调整Breslow厚度和性别后,生存时间没有其他显著的预后因素;Clark分级对5年生存率有显著影响;有丝分裂数、消退证据和血管侵犯对无复发生存时间有显著影响;血管侵犯的存在和有丝分裂数对5年无复发率有显著影响。建议在未来I期黑色素瘤辅助治疗的前瞻性研究中,根据Breslow厚度和性别将患者分层到治疗组。

相似文献

1
Comparison of prognostic factors for survival and recurrence in malignant melanoma of the skin, clinical Stage I.皮肤临床I期恶性黑色素瘤生存和复发的预后因素比较
Cancer. 1985 Mar 1;55(5):1107-17. doi: 10.1002/1097-0142(19850301)55:5<1107::aid-cncr2820550528>3.0.co;2-c.
2
A multifactorial analysis of melanoma: prognostic histopathological features comparing Clark's and Breslow's staging methods.黑色素瘤的多因素分析:比较克拉克(Clark)和布雷斯洛(Breslow)分期方法的预后组织病理学特征
Ann Surg. 1978 Dec;188(6):732-42. doi: 10.1097/00000658-197812000-00004.
3
Clinicopathological Features and Prognostic Factors of Malignant Melanoma: A Retrospective Analysis of Thai Patients in Ramathibodi Hospital.恶性黑色素瘤的临床病理特征及预后因素:拉玛蒂博迪医院泰国患者的回顾性分析
J Med Assoc Thai. 2015 Aug;98(8):820-7.
4
Value of DNA ploidy and S-phase fraction as prognostic factors in stage III cutaneous melanoma.DNA倍体和S期分数作为III期皮肤黑色素瘤预后因素的价值。
Can J Surg. 2000 Feb;43(1):29-34.
5
Treatment Outcome and Prognostic Factors for Malignant Skin Melanoma Treated with Radical Surgery.根治性手术治疗恶性皮肤黑色素瘤的治疗结果及预后因素
Asian Pac J Cancer Prev. 2015;16(14):5709-14. doi: 10.7314/apjcp.2015.16.14.5709.
6
Association between tumor size and Breslow's thickness in malignant melanoma: a cross-sectional, multicenter study.恶性黑色素瘤中肿瘤大小与 Breslow 厚度之间的关联:一项横断面多中心研究。
Melanoma Res. 2015 Oct;25(5):450-2. doi: 10.1097/CMR.0000000000000184.
7
Comparison Among Clark's, Breslow's, and TNM classifications for cutaneous head and neck malignant melanoma.
J Craniofac Surg. 2007 Nov;18(6):1353-8. doi: 10.1097/scs.0b013e3180534453.
8
[Survival analysis in patients with cutaneous malignant melanoma].[皮肤恶性黑色素瘤患者的生存分析]
Srp Arh Celok Lek. 1997 May-Jun;125(5-6):132-7.
9
Updated statistical data for malignant melanoma in Japan.日本恶性黑色素瘤的最新统计数据。
Int J Clin Oncol. 2001 Jun;6(3):109-16. doi: 10.1007/pl00012091.
10
Survival superiority of females with melanoma. A multivariate analysis of 6383 patients exploring the significance of gender in prognostic outcome.
Arch Surg. 1994 Mar;129(3):316-24. doi: 10.1001/archsurg.1994.01420270094020.

引用本文的文献

1
Immune suppression in tumors as a surmountable obstacle to clinical efficacy of cancer vaccines.肿瘤中的免疫抑制是癌症疫苗临床疗效的可克服障碍。
Cancers (Basel). 2011 Jul 18;3(3):2904-54. doi: 10.3390/cancers3032904.
2
Tumor-infiltrating lymphocytes: apparently good for melanoma patients. But why?肿瘤浸润淋巴细胞:似乎对黑色素瘤患者有益。但原因是什么?
Cancer Immunol Immunother. 2011 Aug;60(8):1153-60. doi: 10.1007/s00262-011-1026-2. Epub 2011 May 7.
3
Melanoma sentinel node biopsy and prediction models for relapse and overall survival.
黑色素瘤前哨淋巴结活检和复发及总生存预测模型。
Br J Cancer. 2010 Oct 12;103(8):1229-36. doi: 10.1038/sj.bjc.6605849. Epub 2010 Sep 21.
4
Groin dissection in malignant melanoma.恶性黑色素瘤的腹股沟淋巴结清扫术
Ann Surg Oncol. 1994 Jul;1(4):271-7. doi: 10.1007/BF02303564.
5
Prognostic role of antibody reactivity to melanoma.抗体对黑色素瘤反应性的预后作用。
J Clin Invest. 1986 Apr;77(4):1116-21. doi: 10.1172/JCI112410.
6
The prognosis of primary and metastasising melanoma. An evaluation of the TNM classification in 2,495 patients.原发性和转移性黑色素瘤的预后。对2495例患者TNM分类的评估。
Br J Cancer. 1992 Nov;66(5):856-61. doi: 10.1038/bjc.1992.373.